Almeda Pu AI Stock Analysis
Want to see IL:AMDA full AI Analyst Report?
Almeda Pu (AMDA) AI Stock Analysis
Almeda Pu
(TASE:AMDA)
Almeda Pu receives a moderate overall score, bolstered by a pristine, debt-free balance sheet and exceptionally attractive valuation metrics including a high dividend yield. However, critical risks offset these strengths, most notably the company's inability to generate positive cash flow despite high reported earnings, indicating a heavy reliance on non-cash accounting gains. Additionally, technical indicators show the stock stuck in a definitive bearish trend below all major moving averages.
Almeda Pu (AMDA) vs. iShares MSCI Israel ETF (EIS)
- Market Cap
- ILS 33.81M
- Dividend Yield
- 108.63%
- Average Volume (3M)
- 37.86K
- Price to Earnings (P/E)
- 1.0
- Beta (1Y)
- -0.12
- Revenue Growth
- -52.44%
- EPS Growth
- ―
- Country
- Israel
- Employees
- 2
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Asset Management
Almeda Pu Business Overview & Revenue Model
Company Description
Almeda Ventures Limited Partnership, established in Tel Aviv, Israel, in 2020, functions as a venture capital firm. The partnership strategically deploys capital across various development stages, including seed, startup, early-stage, and established...
Almeda Pu Financial Statement Overview
Summary
Almeda Pu boasts a debt-free balance sheet and impressive net income margins. However, persistent negative free cash flow suggests earnings are largely driven by non-cash gains rather than sustainable cash generation.
Income Statement
82Very PositiveBalance Sheet
95Very PositiveCash Flow
30Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.74M | 87.68K | -3.02M | -292.00K | 907.00K | 1.60M |
| Gross Profit | 10.73M | -57.37K | -3.04M | -328.00K | 852.00K | 1.56M |
| EBITDA | 9.94M | 1.91M | -4.28M | -1.55M | -562.00K | 98.00K |
| Net Income | 9.97M | 1.89M | -4.20M | -1.58M | -641.00K | 52.00K |
Balance Sheet | ||||||
| Total Assets | 30.87M | 25.96M | 23.08M | 25.71M | 27.28M | 27.91M |
| Cash, Cash Equivalents and Short-Term Investments | 13.33M | 4.40M | 2.35M | 2.91M | 5.93M | 9.54M |
| Total Debt | 0 | 0 | 15.00K | 73.00K | 147.00K | 243.00K |
| Total Liabilities | 93.00K | 125.03K | 442.00K | 405.00K | 393.00K | 545.00K |
| Stockholders Equity | 30.78M | 25.84M | 22.64M | 25.31M | 26.88M | 27.37M |
Cash Flow | ||||||
| Free Cash Flow | -982.00K | -1.07M | -1.09M | -1.13M | -1.46M | -1.29M |
| Operating Cash Flow | -982.00K | -1.07M | -1.09M | -1.13M | -1.46M | -1.28M |
| Investing Cash Flow | 13.23M | -476.29K | -1.41M | -3.57M | -2.15M | -9.93M |
| Financing Cash Flow | -947.00K | 1.54M | 1.48M | -73.00K | 59.00K | 8.24M |
Almeda Pu Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AMDA, the sentiment is Negative. The current price of 174.30 is below the 20-day moving average (MA) of 214.68, below the 50-day MA of 235.63, and below the 200-day MA of 204.80, indicating a bearish trend. The MACD of -20.99 indicates Positive momentum. The RSI at 29.66 is Positive, neither overbought nor oversold. The STOCH value of 60.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:AMDA.
Almeda Pu Peers Comparison
Overall Rating
IL:AMDA65Neutral
IL:BLRX41Neutral
IL:CANF37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 65Neutral | ILS 33.81M | 0.99 | ― | 108.63% | -52.44% | ― | |
| 41Neutral | ILS 29.92M | -0.96 | ― | ― | -93.07% | 62.25% | |
| 37Underperform | ILS 15.37M | -0.21 | ― | ― | ― | ― |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IL:AMDA | Almeda Ventures Limited Partnership | 174.30 | 49.65 | 39.84% | |
| IL:CBI | Clal Biotechnology Industries Ltd | 19.00 | -15.00 | -44.12% | |
| IL:BLRX | BioLineRX Ltd. | 1.00 | -0.80 | -44.44% | |
| IL:CANF | Can-Fite BioPharma Ltd. | 245.10 | 244.10 | 24410.00% | |
| IL:ALMD | Allmed Solutions Ltd. | 29.40 | -1.10 | -3.61% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026